Does Oscar Health Cover Ozempic?
The verdict
Conditional on most plans
Oscar Health covers Ozempic for type 2 diabetes with prior authorization across its commercial and ACA/individual plans. No Oscar plan covers Ozempic for off-label weight-loss use — Ozempic is FDA-approved only for T2D glycemic control, cardiovascular risk reduction in T2D patients with known CVD, and CKD progression in T2D patients. Weight-loss seekers will be denied.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Oscar Health using your member ID.
Key facts
Ozempic is FDA-approved for type 2 diabetes glycemic control, cardiovascular risk reduction in T2D patients with known CVD, and CKD progression in T2D patients — not for weight loss.
FDA drug labeling (semaglutide injection)
Oscar Health operates primarily in ACA individual and small-group markets; its formulary details are not publicly published at the drug level — verify via the Oscar member app.
Oscar Health member resources, hioscar.com
The NovoCare Ozempic Savings Card offers commercially insured T2D patients as little as $25 per fill (max $150/28-day supply); not available to Medicare or Medicaid beneficiaries.
NovoCare, Ozempic Savings Offers
Medicare vs. commercial coverage
Whether Oscar Health covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D: Oscar has a limited Medicare Advantage presence. Where applicable, Ozempic is covered for type 2 diabetes with prior authorization under standard Part D rules. The 2026 Part D out-of-pocket cap is $2,100. Medicare beneficiaries cannot use the NovoCare savings card — federal anti-kickback rules exclude Medicare and Medicaid enrollees. Ozempic is not covered for weight loss under Medicare Part D; off-label weight-loss use is statutorily excluded. The IRA Maximum Fair Price for semaglutide is $274 per 30-day supply, effective January 1, 2027. Verify on your specific Oscar Medicare plan formulary.
Commercial / Employer
Group & marketplace plans
Commercial/Small Group and ACA/Individual: Ozempic is covered for type 2 diabetes with prior authorization and step therapy — this is Oscar's core business. Oscar operates ACA individual and small-group plans across multiple states; formulary tier and cost-share are not publicly published at the drug level and vary by state-specific plan. Verify via the Oscar drug lookup app or member portal. Commercially insured T2D patients may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150 per 28-day supply) — verify at NovoCare.com. Ozempic is not covered for off-label weight loss on any Oscar commercial or ACA plan. Medicaid: Oscar participates in Medicaid managed care in select states; covered for T2D with PA and nominal cost-share per state PDL. Not covered for weight loss.
The 3 boxes you must tick to get approved
Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,028/month (Novo Nordisk published pricing, ~$1,027.51 for the 0.25/0.5 mg pen). NovoCare self-pay: ~$199/month intro price (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial/ACA plan cost-share not publicly published for Oscar's state-specific plans — varies by formulary tier and plan design. Verify on Oscar's drug lookup tool. Medicare Part D (where applicable): cost-share per tier; $2,100 OOP cap 2026. IRA Maximum Fair Price of $274/30-day for semaglutide takes effect January 1, 2027 for Medicare patients.
Typical monthly copay once prior authorization is approved.
Bridge program
NovoCare Ozempic Savings Card: commercially insured T2D patients on an Oscar commercial or ACA plan may pay as little as $25 per fill (max $150 per 28-day supply). Not available to Medicare or Medicaid beneficiaries. Verify eligibility at NovoCare.com.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Tier placement and cost-share vary by Oscar plan and state. Confirm exact cost with Oscar member services or via the Oscar drug lookup tool before filling.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Use the Oscar drug lookup tool or app
Log in to your Oscar account at hioscar.com or the Oscar app and search for Ozempic to confirm it appears on your specific plan's formulary, its tier, and any prior-authorization or step-therapy requirements. Oscar's formulary is not published at the drug level outside the member portal — the app is the primary verification path.
- 2
Have your prescriber initiate prior authorization for T2D
Your prescriber submits the PA through Oscar. Required documentation typically includes: a type 2 diabetes diagnosis (ICD-10 E11.x), evidence of a metformin trial or documented intolerance/contraindication, and the clinical indication (T2D glycemic control — not weight management). If Oscar requires an additional oral agent step, your prescriber's chart notes should reflect that history.
- 3
Check the NovoCare savings card if you have commercial coverage
If you are enrolled in an Oscar commercial or ACA plan (not Medicare or Medicaid), you may qualify for the NovoCare Ozempic Savings Card at $25/fill. Visit NovoCare.com to confirm eligibility. Medicare and Medicaid enrollees cannot use this card due to federal anti-kickback rules.
Options if Oscar Health won't cover Ozempic
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Rybelsus (oral semaglutide)
Oral semaglutide for type 2 diabetes. May be on a different formulary tier than Ozempic on Oscar plans — verify via Oscar drug lookup. Also subject to IRA Maximum Fair Price of $274/30-day effective January 1, 2027 for Medicare patients.
Jardiance (empagliflozin)
SGLT-2 inhibitor commonly required as step therapy before GLP-1 approval on some formularies. Often a preferred brand tier with lower cost-share than Ozempic.
Metformin (generic)
Tier 1 generic on virtually all formularies at $0–$4 copay. Required as step therapy before Ozempic PA approval on most Oscar plans.
Compounded semaglutide (weight-loss seekers only)
For patients seeking semaglutide for weight management — not T2D — who are denied under Oscar's ACA or commercial plans, compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the offer section below for full disclaimers.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Oscar Health does not cover Ozempic for weight loss under any plan. Ozempic is FDA-approved only for type 2 diabetes — not for weight management. No insurer covers Ozempic for off-label weight-loss use. Oscar's ACA and commercial plans serve a younger population, many of whom search for Ozempic for weight loss; the answer is a firm denial regardless of plan type. Patients seeking semaglutide for weight management should explore weight-loss-specific options.
Yes, Oscar covers Ozempic for type 2 diabetes with prior authorization on its ACA individual and small-group plans. Your prescriber must submit a PA documenting your T2D diagnosis and evidence of step therapy (metformin trial or documented intolerance). Specific tier and cost-share are not publicly published for Oscar's state-specific ACA plans — verify via the Oscar app or member portal to confirm your plan's formulary placement and PA criteria.
Yes, if you are enrolled in an Oscar commercial or ACA plan (not Medicare or Medicaid). The NovoCare Ozempic Savings Card offers commercially insured T2D patients as little as $25 per fill (max $150 per 28-day supply). Oscar's primarily commercial and ACA membership makes this card relevant for most Oscar enrollees. Verify your eligibility at NovoCare.com — Medicare and Medicaid beneficiaries are excluded by federal anti-kickback rules.
Oscar's formulary is not publicly published at the drug level outside the member portal. Use the Oscar app or log in at hioscar.com to search for Ozempic under your specific plan. The search will show the tier, prior-authorization requirements, and any step-therapy criteria. If you need help, Oscar's member services team can confirm coverage details for your specific state and plan type. Oscar's digital-first approach makes the app the fastest verification path.
Oscar requires prior authorization for Ozempic for type 2 diabetes. PA generally requires a documented T2D diagnosis and evidence of metformin use (or documented intolerance/contraindication). Specific Oscar PA criteria are not confirmed in a publicly available primary formulary document — they vary by state-specific plan. Have your prescriber verify the exact requirements via Oscar's PA portal or by calling member services before submitting the PA to avoid delays.
Related Articles
Does Oscar Health Cover Phentermine (Adipex-P)? 2026 | Curex
Oscar Health marketplace plans frequently exclude phentermine as an AOM. But the generic is just $10–$40 cash — coverage rarely matters here.
Read moreDoes Oscar Health Cover Propecia? Hair Loss 2026 | Curex
Oscar Health does not cover Propecia for hair loss — cosmetic exclusion applies. Finasteride 5 mg (Proscar) IS covered as a Tier 1 generic for BPH.
Read moreDoes Oscar Health Cover Farxiga? Coverage & Cost 2026
Yes — Oscar covers Farxiga on commercial and ACA plans; metformin-first step likely. Tier not public — use Oscar app. Generic dapagliflozin now available.
Read moreDoes Oscar Health Cover Eliquis? Coverage & Cost 2026
Yes — Oscar Health covers Eliquis for AFib and VTE on commercial and ACA plans. Tier unpublished — use Oscar's drug lookup. IRA price $231 for Medicare.
Read moreDoes Oscar Health Cover Contrave? 2026 ACA Guide | Curex
Oscar marketplace plans frequently exclude Contrave. Where covered, BMI prior auth applies. CurAccess ~$99/mo beats the retail price for most members.
Read moreDoes Oscar Health Cover Adderall? 2026 Coverage Guide | Curex
Oscar Health covers Adderall via its PBM — generic preferred low-tier, brand non-preferred. Tier not published; use Oscar drug lookup to confirm.
Read moreInsurance won't cover Ozempic for weight loss — here's a path that doesn't need it
Oscar's ACA and commercial plans do not cover Ozempic for weight loss — and no insurer does. Many Oscar members searching 'does Oscar cover Ozempic' are weight-loss seekers who will be denied. Curex offers compounded semaglutide starting at $49/mo with no insurance required and no prior authorization. Compounded semaglutide is not the same medication as Ozempic or Wegovy. Compounded tirzepatide is also available from $149/mo. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Oscar Health before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.